Waging Hope Together

If you've been hanging around here for very long, you'll know that we are Big Supporters of  The Pancreatic Cancer Action Network.  There are many great organizations out there... we have just been drawn to PanCan's mission statement over and over again.

They are passionate and dedicated about fighting this monstrous cancer and hit it on all fronts...

- Research
- Clinical Initiatives
- Patient Services
- Advocacy

Their ambitious goal is to double pancreatic cancer survival rates by the year 2020... Funds will be used to:

- develop early detection tools and better treatment options
- push for more federal funding for pancreatic cancer research
- increase funding for patient services, such as the Know Your Tumor program and options to join clinical trials targeted to match patients needs.
- focus attention on pancreatic cancer and help patients and their families Wage Hope and rewrite the future of pancreatic cancer survival.

And PanCan fund raises with a ferocious urgency to push forward the research that will take us to that cure.

The cure is so close!

Each year the PanCan Research Fund awards grants to scientists in an effort to advance the field and pursue breakthroughs in pancreatic cancer treatment.

This year's Grant Recipients for the PanCan Research Fund are:

Please join us in welcoming this year’s new grantees and sharing this announcement:

2018 Skip Viragh Pancreatic Cancer Action Network Catalyst Grant
Andrew Aguirre, MD, PhD
Dana-Farber Cancer Institute
Functional Genetic Discovery of Novel Targets in Pancreatic Cancer

2018 Pancreatic Cancer Action Network Translational Research Grant
Darren Carpizo, MD, PhD, Rutgers, The State University of New Jersey
Co-PI: Patrick Mehlen, PhD, Université Claude Bernard Lyon 1
Investigating Netrin-1 as a New Therapeutic Target in Pancreatic Cancer

2018 Pancreatic Cancer Action Network Catalyst Grant
Iok In Christine Chio, PhD
Columbia University Medical Center
Targeting Redox Status and mRNA translation in Pancreatic Cancer

2018 Pancreatic Cancer Action Network Translational Research Grant
Michael Curran, PhD
MD Anderson Cancer Center
Pro-Inflammatory Conversion of the PDAC Microenvironment

2018 Pancreatic Cancer Action Network Translational Research Grant
Sharon Gorski, PhD, British Columbia Cancer Agency Branch (BC Cancer)
Co-PI: Robert Young, PhD, MC, FRSC, Simon Fraser University
ATG4 Family Members as Therapeutic Targets for Pancreatic Cancer

2018 Pancreatic Cancer Action Network Translational Research Grant
Scott Lowe, PhD
Sloan-Kettering Institute for Cancer Research
Targeting p53 Mutations in Pancreatic Ductal Adenocarcinoma

2018 Skip Viragh Pancreatic Cancer Action Network Career Development Award
Karen Mann, PhD
Moffitt Cancer Center
RBFOX2-Mediated Alternative Splicing in Pancreatic Cancer Metastasis

2018 Pancreatic Cancer Action Network Translational Research Grant
George Miller, MD
Co-PI: Shohei Koide, PhD
Perlmutter Cancer Center at NYU Langone
Central Role of TIM4 in Driving Immune Tolerance in Pancreatic Carcinoma

2018 Pancreatic Cancer Action Network Translational Research Grant
Kenneth Shroyer, MD, PhD
Stony Brook University
Keratin 17 Is a Novel Actionable Target in Pancreatic Ductal Adenocarcinoma

Promoting the next level of treatments... Pushing towards the cure, a bit closer every day!

We call this SUCCESS of the best kind.  Thank you PanCan for all you do on our behalf.

And that is Good News for today,

Always,
        Jane